Following on from the success of our Pitch Battle in April, we sought to encourage the peer mentorship within our community. As the BioEscalator ecosystem currently comprises 13 high-growth companies in the early funding stages of seed to post series A, we were keen to utilise this wealth of knowledge and experience to support our companies in the process of raising series A, by matching our top start-ups with mentors from within our company pool. After 3 weeks of training and feedback on their business plans and investor slide decks, Theolytics, who are developing oncolytic viruses as therapeutics, Alchemab Therapeutics, who are utilising native antibodies and a novel platform to discover new therapeutics and Bioarchitech, who are developing novel oncolytic viral therapies, all gave excellent 6 minute pitches to our esteemed judging panel.
Theolytics announced winners of the Santander Pitch Finale
24 June 2020
Following a fantastic event, Theolytics was announced the winner of the BioEscalator’s inaugural Pitch Finale, which was kindly supported by Santander Universities UK.